From flamingo dance to (desirable) drug discovery: A nature-inspired approach

Aminael Sánchez-Rodríguez, Yunierkis Pérez-Castillo, Stephan C Schuerer, Orazio Nicolotti, Giuseppe Felice Mangiatordi, Fernanda Borges, M. Natalia D.S. Cordeiro, Eduardo Tejera, José L. Medina-Franco, Maykel Cruz-Monteagudo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The therapeutic effects of drugs are well known to result from their interaction with multiple intracellular targets. Accordingly, the pharma industry is currently moving from a reductionist approach based on a 'one-target fixation' to a holistic multitarget approach. However, many drug discovery practices are still procedural abstractions resulting from the attempt to understand and address the action of biologically active compounds while preventing adverse effects. Here, we discuss how drug discovery can benefit from the principles of evolutionary biology and report two real-life case studies. We do so by focusing on the desirability principle, and its many features and applications, such as machine learning-based multicriteria virtual screening. Here, we describe a multicriteria virtual screening approach based on desirability functions and tailored ensemble machine-learning classifiers.

Original languageEnglish (US)
JournalDrug Discovery Today
DOIs
StateAccepted/In press - 2017

Fingerprint

Drug Discovery
Therapeutic Uses
Industry
Pharmaceutical Preparations
Machine Learning

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Sánchez-Rodríguez, A., Pérez-Castillo, Y., Schuerer, S. C., Nicolotti, O., Mangiatordi, G. F., Borges, F., ... Cruz-Monteagudo, M. (Accepted/In press). From flamingo dance to (desirable) drug discovery: A nature-inspired approach. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2017.05.008

From flamingo dance to (desirable) drug discovery : A nature-inspired approach. / Sánchez-Rodríguez, Aminael; Pérez-Castillo, Yunierkis; Schuerer, Stephan C; Nicolotti, Orazio; Mangiatordi, Giuseppe Felice; Borges, Fernanda; Cordeiro, M. Natalia D.S.; Tejera, Eduardo; Medina-Franco, José L.; Cruz-Monteagudo, Maykel.

In: Drug Discovery Today, 2017.

Research output: Contribution to journalArticle

Sánchez-Rodríguez, A, Pérez-Castillo, Y, Schuerer, SC, Nicolotti, O, Mangiatordi, GF, Borges, F, Cordeiro, MNDS, Tejera, E, Medina-Franco, JL & Cruz-Monteagudo, M 2017, 'From flamingo dance to (desirable) drug discovery: A nature-inspired approach', Drug Discovery Today. https://doi.org/10.1016/j.drudis.2017.05.008
Sánchez-Rodríguez, Aminael ; Pérez-Castillo, Yunierkis ; Schuerer, Stephan C ; Nicolotti, Orazio ; Mangiatordi, Giuseppe Felice ; Borges, Fernanda ; Cordeiro, M. Natalia D.S. ; Tejera, Eduardo ; Medina-Franco, José L. ; Cruz-Monteagudo, Maykel. / From flamingo dance to (desirable) drug discovery : A nature-inspired approach. In: Drug Discovery Today. 2017.
@article{0426d96ad3044e6dbc0d81ae418617dd,
title = "From flamingo dance to (desirable) drug discovery: A nature-inspired approach",
abstract = "The therapeutic effects of drugs are well known to result from their interaction with multiple intracellular targets. Accordingly, the pharma industry is currently moving from a reductionist approach based on a 'one-target fixation' to a holistic multitarget approach. However, many drug discovery practices are still procedural abstractions resulting from the attempt to understand and address the action of biologically active compounds while preventing adverse effects. Here, we discuss how drug discovery can benefit from the principles of evolutionary biology and report two real-life case studies. We do so by focusing on the desirability principle, and its many features and applications, such as machine learning-based multicriteria virtual screening. Here, we describe a multicriteria virtual screening approach based on desirability functions and tailored ensemble machine-learning classifiers.",
author = "Aminael S{\'a}nchez-Rodr{\'i}guez and Yunierkis P{\'e}rez-Castillo and Schuerer, {Stephan C} and Orazio Nicolotti and Mangiatordi, {Giuseppe Felice} and Fernanda Borges and Cordeiro, {M. Natalia D.S.} and Eduardo Tejera and Medina-Franco, {Jos{\'e} L.} and Maykel Cruz-Monteagudo",
year = "2017",
doi = "10.1016/j.drudis.2017.05.008",
language = "English (US)",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - From flamingo dance to (desirable) drug discovery

T2 - A nature-inspired approach

AU - Sánchez-Rodríguez, Aminael

AU - Pérez-Castillo, Yunierkis

AU - Schuerer, Stephan C

AU - Nicolotti, Orazio

AU - Mangiatordi, Giuseppe Felice

AU - Borges, Fernanda

AU - Cordeiro, M. Natalia D.S.

AU - Tejera, Eduardo

AU - Medina-Franco, José L.

AU - Cruz-Monteagudo, Maykel

PY - 2017

Y1 - 2017

N2 - The therapeutic effects of drugs are well known to result from their interaction with multiple intracellular targets. Accordingly, the pharma industry is currently moving from a reductionist approach based on a 'one-target fixation' to a holistic multitarget approach. However, many drug discovery practices are still procedural abstractions resulting from the attempt to understand and address the action of biologically active compounds while preventing adverse effects. Here, we discuss how drug discovery can benefit from the principles of evolutionary biology and report two real-life case studies. We do so by focusing on the desirability principle, and its many features and applications, such as machine learning-based multicriteria virtual screening. Here, we describe a multicriteria virtual screening approach based on desirability functions and tailored ensemble machine-learning classifiers.

AB - The therapeutic effects of drugs are well known to result from their interaction with multiple intracellular targets. Accordingly, the pharma industry is currently moving from a reductionist approach based on a 'one-target fixation' to a holistic multitarget approach. However, many drug discovery practices are still procedural abstractions resulting from the attempt to understand and address the action of biologically active compounds while preventing adverse effects. Here, we discuss how drug discovery can benefit from the principles of evolutionary biology and report two real-life case studies. We do so by focusing on the desirability principle, and its many features and applications, such as machine learning-based multicriteria virtual screening. Here, we describe a multicriteria virtual screening approach based on desirability functions and tailored ensemble machine-learning classifiers.

UR - http://www.scopus.com/inward/record.url?scp=85021071373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021071373&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2017.05.008

DO - 10.1016/j.drudis.2017.05.008

M3 - Article

C2 - 28624633

AN - SCOPUS:85021071373

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

ER -